Advertisement
Screener

SYRA HEALTH CORP. (SYRA) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1.7 / 5 stars · 10/29 Roast Me

SYRA HEALTH CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

SYRA HEALTH CORP. (SYRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 278.92 thousand shares for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-14.

Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-09-14

  • SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 21.00K shares.
  • SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 257.92K shares, a 347.42% increase year-over-year.
  • SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 263.39K shares, a 259.09% increase year-over-year.
  • SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 57.65K shares, a 140.19% increase year-over-year.
  • SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 115.35K shares, a 2.31% increase from fiscal 2023.
  • SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 112.75K shares, a 189.10% increase from fiscal 2022.
  • SYRA HEALTH CORP. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 39.00K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month
2026-06-3021.00K shares
derived: S-1 6 month − 10-Q 3 month · filed 2026-09-14
278.92K shares
S-1 · filed 2026-09-14
542.31K shares
derived: sum of 3 quarters · filed 2026-09-14
2026-03-31257.92K shares
10-Q · filed 2026-05-07
521.31K shares
derived: sum of 2 quarters · filed 2026-09-14
2025-12-31263.39K shares
derived: S-1 12 month − 10-Q 9 month · filed 2026-09-14
346.04K shares
S-1 · filed 2026-09-14
2025-09-3082.65K shares
10-Q · filed 2025-11-12
2025-03-3157.65K shares
10-Q · filed 2025-08-12
131.00K shares
derived: sum of 2 quarters · filed 2025-08-12
141.00K shares
derived: sum of 3 quarters · filed 2025-08-12
149.00K shares
derived: sum of 4 quarters · filed 2025-08-12
2024-12-3173.35K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
83.35K shares
derived: sum of 2 quarters · filed 2025-03-11
91.35K shares
derived: sum of 3 quarters · filed 2025-03-11
115.35K shares
10-K · filed 2025-03-11
2024-09-3010.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
18.00K shares
derived: sum of 2 quarters · filed 2024-10-29
42.00K shares
10-Q · filed 2024-10-29
2024-06-308.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
32.00K shares
10-Q · filed 2024-08-08
2024-03-3124.00K shares
10-Q · filed 2024-05-09
2023-12-31112.75K shares
10-K · filed 2024-03-25
2022-12-3139.00K shares
10-K · filed 2024-03-25